Answers are grounded in this paper and cite their sources.
The authors suggest that placebo-controlled trials in osteoporosis are nearly always unethical, since several drugs that materially decrease the risk of fractures in such patients are currently available.
No takes yet. Share an insight, caveat, or question.
Stein et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: